King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Mohamad Walid Ballourah
Dr. Mohamad Walid Ballourah is a Senior Consultant in Pediatric Hematology/Oncology with deep sub-specialty focus on childhood leukaemia and lymphoma. He is a trusted Pediatric Hematology/Oncology specialist for children referred from across the Middle East.
- 15+ years of clinical experience in paediatric haematology and oncology
- Sub-specialty expertise in childhood ALL, AML, Hodgkin and non-Hodgkin lymphoma
- Manages 100+ new paediatric cancer cases each year within a high-volume cancer programme
- Active in regional paediatric oncology research collaborations across the Middle East
- Experienced in treating international paediatric patients in Riyadh, Saudi Arabia
Qualifications & Credentials
Medical Degrees
- MBBS — Medical University
- Paediatric Residency Training
Fellowships & Special Training
- Fellowship in Pediatric Hematology / Oncology
- Advanced training in Childhood Leukaemia / Lymphoma
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — American Society of Hematology (ASH)
- Member — International Society of Paediatric Oncology (SIOP)
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukaemia (ALL) in Children
- Acute Myeloid Leukaemia (AML) in Children
- Hodgkin Lymphoma (Paediatric)
- Non-Hodgkin Lymphoma (Paediatric)
- Paediatric Solid Tumours
- Childhood Neuroblastoma
- Paediatric Bone Marrow Failure Syndromes
Sub-specialties
- Childhood Leukaemia & Lymphoma: Risk-adapted chemotherapy protocols — a trusted Pediatric Hematology/Oncology specialist in Riyadh, Saudi Arabia for international families.
- High-Dose Methotrexate Therapy: Safe administration and management of delayed methotrexate elimination, a documented research interest.
- Late Effects of Childhood Cancer: Long-term survivorship care for paediatric cancer survivors.
Advanced Procedures & Treatments
- Risk-Stratified Chemotherapy for Paediatric ALL and AML
- High-Dose Methotrexate Protocols with Leucovorin Rescue
- Intrathecal Chemotherapy
- Targeted Therapies (Imatinib, Blinatumomab in Paediatric ALL)
- Supportive Care & Management of Chemotherapy Toxicities
- Survivorship & Late-Effects Clinic Care
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital and Research Centre (KFSHRC), Riyadh, Saudi Arabia — Consultant, Leukemia-Lymphoma Section, Department of Pediatric Hematology/Oncology (Present)
Past Affiliations
- King Fahad Medical City, Riyadh, Saudi Arabia — Department of Pediatric Hematology (prior affiliation)
Academic & Research Roles
- Member — Middle East Pediatric Hematology Oncology Network
- Participant — Multidisciplinary Paediatric Tumour Board
Key Achievements
- Co-author of a regional Middle East consensus on delayed methotrexate elimination in high-dose therapy (Frontiers in Oncology, 2025)
- Contributor to a multicentre Saudi study on late effects of childhood cancer (ASH Annual Meeting, 2024)
- Cares for children with leukaemia/lymphoma within a programme that treats hundreds of new paediatric cancer cases yearly
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Hematology (ASH)
- International Society of Paediatric Oncology (SIOP)
- Saudi Society of Haematology
Research & Publications
Published Papers (Selected)
- Alabbas F, Alharbi I, Ahmad N, Alnajashi K, Ballourah W, Alsultan A. "Late Effects of Childhood Cancer Among Survivors in Saudi Arabia: A Multicenter Cross-Sectional Study." Blood. 2024;144(Supplement 1):5861. DOI:10.1182/blood-2024-201602
- Ballourah W et al. "Consensus on managing delayed methotrexate elimination in high-dose therapy: insights from the Middle East." Frontiers in Oncology. 2025. DOI:10.3389/fonc.2025.1660937
Ongoing Research & Clinical Interests
- High-dose methotrexate safety in paediatric oncology
- Late effects and survivorship of childhood cancer
- Risk-adapted protocols for paediatric ALL in Saudi population
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (SAR) | Estimated Cost (USD) |
|---|---|---|
| Pediatric Oncology Consultation | SAR 400 – SAR 1,000 | $110 – $265 |
| Paediatric Chemotherapy (per cycle) | SAR 5,000 – SAR 25,000 | $1,335 – $6,660 |
| High-Dose Methotrexate Protocol | SAR 8,000 – SAR 20,000 | $2,135 – $5,335 |
| Bone Marrow Aspiration / Biopsy | SAR 2,500 – SAR 5,000 | $665 – $1,335 |
| Comprehensive Leukaemia Workup (Flow, Cytogenetics, MRD) | SAR 5,000 – SAR 15,000 | $1,335 – $4,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Mohamad Walid Ballourah use in Pediatric Hematology / Oncology treatment?
Dr. Mohamad Walid Ballourah uses modern risk-stratified chemotherapy protocols, minimal residual disease (MRD) monitoring, high-dose methotrexate with safe elimination monitoring, intrathecal chemotherapy, and paediatric targeted agents such as blinatumomab and imatinib. Remote second opinions on paediatric cancer cases are available via Cancer Rounds.
2. What conditions does Dr. Mohamad Walid Ballourah specialize in treating?
Dr. Mohamad Walid Ballourah is a Pediatric Hematology / Oncology specialist treating childhood acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), Hodgkin and non-Hodgkin lymphoma, paediatric solid tumours and bone marrow failure syndromes. Families from the Gulf and Africa seek his expertise for complex paediatric cancer care in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Mohamad Walid Ballourah?
Appointments with Dr. Mohamad Walid Ballourah can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Mohamad Walid Ballourah?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mohamad Walid Ballourah, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Mohamad Walid Ballourah offer second opinions for Pediatric Hematology / Oncology cases?
Yes. Second opinion consultations for childhood leukaemia, lymphoma and paediatric cancers can be arranged via Cancer Rounds with Dr. Mohamad Walid Ballourah, an expert Pediatric Hematology / Oncology specialist in Riyadh, Saudi Arabia.
